Evaluation of Treatment Results with Direct Acting Antiviral Drugs of Cirrhotic/Non-cirrhotic Chronic Liver Disease Caused by Hepatitis C Virus Genotype 1b Infection
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.26, no.2, pp.43-48, 2020 (ESCI, TRDizin)
- Publication Type: Article / Article
- Volume: 26 Issue: 2
- Publication Date: 2020
- Doi Number: 10.4274/vhd.galenos.2020.2020.0016
- Journal Name: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
- Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
- Page Numbers: pp.43-48
- Istanbul University Affiliated: No
Abstract
Objectives: This study aimed to investigate the effect of treatment with direct-acting antivirals (DAAs) on the virological response and on the some parameters used to evaluate liver function in cases with chronic liver disease due to hepatitis C virus (HCV) genotype 1b.